SEC Form 4 research
| Issuer | Acasti Pharma Inc. |
|---|---|
| Tickers | ACST, GRCE |
| Reporting owners | 24 |
| Officers and directors | 3 |
| Last public filing | 2026-11-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-05 | 2026-11-05 | Opaleye Management Inc. | P | 3,087 | $1.77 | Not reported |
| 2026-11-05 | 2026-11-04 | Opaleye Management Inc. | P | 5,027 | $1.8 | Not reported |
| 2026-11-05 | 2026-11-03 | Opaleye Management Inc. | P | 10,328 | $1.79 | Not reported |
| 2026-10-26 | 2026-10-26 | Opaleye Management Inc. | P | 66,411 | $1.77 | Not reported |
| 2026-10-26 | 2026-10-22 | Opaleye Management Inc. | P | 21,390 | $1.93 | Not reported |
| 2026-10-21 | 2026-10-19 | Opaleye Management Inc. | P | 4,256 | $1.88 | Not reported |
| 2026-10-16 | 2026-10-16 | Opaleye Management Inc. | P | 36,347 | $1.89 | Not reported |
| 2026-10-16 | 2026-10-15 | Opaleye Management Inc. | P | 23,485 | $1.95 | Not reported |
| 2026-10-16 | 2026-10-14 | Opaleye Management Inc. | P | 11,233 | $1.93 | Not reported |
| 2026-10-13 | 2026-10-12 | Opaleye Management Inc. | P | 7,215 | $2.02 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.